Traditional Chinese medicine decoction for treating asthma and preparing method thereof

Abstract

The invention relates to a traditional Chinese medicine decoction for treating asthma and a preparing method thereof and belongs to the technical field of medicine. The traditional Chinese medicine decoction is prepared from, by weight, 8-16 parts of herb of black medick, 12-18 parts of rock cotoneaster twig and leaf or root, 15-20 parts of all-grass of ovate neolepisorus, 10-15 parts of herb of flexuose climbing fern, 3-6 parts of fructus chebulae, 8-16 parts of paulownia fruit, 12-18 parts of sorghum root, 3-7 parts of muskroot-like semiaquilegia root, 12-16 parts of cymbidium root, 3-6 parts of exocarpium, 10-18 parts of argyreia acuta lour, 3-9 parts of fructus aristolochiae, 6-12 parts of radix polygonati officinalis, 10-15 parts of Junesnow herb, 12-18 parts of glutinous rice rhizome and root and 9-15 parts of walnut kernel. The traditional Chinese medicine decoction can clear heat and promote diuresis, moisten lung and relieve sore-throat, eliminate phlegm and stop cough, regulate qi and remove stasis, calm the adverse-rising energy and relieve asthma, dispel wind and remove dampness, tonify spleen and kidney and the like, and when the traditional Chinese medicine decoction is used for treating asthma, the treatment effect is remarkable, relapse does not occur easily after healing, no toxic or side effect is caused, and safety performance is high.

Description

【Technical field】 [0001] The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine decoction for treating asthma and a preparation method thereof. 【technical background】 [0002] Asthma is a common and frequently-occurring disease. It is a chronic airway inflammation involving a variety of cells, especially mast cells, eosinophils, and T lymphocytes. In susceptible individuals, this inflammation can cause recurrent wheezing. Symptoms such as shortness of breath, chest tightness and (or) cough, and a small number of patients may also have chest pain as the main manifestation. Over the past ten years, the prevalence and mortality of asthma in the United States, the United Kingdom, Australia, New Zealand and other countries have been on the rise. There are about 100 million asthma patients in the world, and it has become a major chronic disease that seriously threatens public health. [0003] The pathogenesis of asthma includes: ...

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of asthma mostly adopts a combination of Chinese and Western methods, and the drugs mostly use aminophylline, ephedrine, diphenhydramine and antibiotics. Although these drugs can provide temporary relief, most of them cannot target the cause of asthma Treat the symptoms, not the root cause, and relapse easily after drug withdrawal, and some drugs have relatively large side effects, so they cannot be taken for a long time; commonly used Chinese patent medicines Qingfei Capsules, Chuanbei Tablets, etc., have small side effects, but slow curative effect and long course of treatment. The effect is not very obvious